Literature DB >> 30721837

Effects of menstrual cycle phase on associations between the error-related negativity and checking symptoms in women.

Elizabeth M Mulligan1, Greg Hajcak2, Julia Klawohn3, Brady Nelson4, Alexandria Meyer3.   

Abstract

The menstrual cycle is known to impact mood and cognitive function and has been shown to lead to variability in symptoms of obsessive-compulsive disorders and anxiety. Using a within-subject design, the present study examined ovarian hormones, the error-related negativity (ERN), and self-reported checking symptoms in both the mid-follicular and mid-luteal phases of the menstrual cycle. ERN amplitude and checking symptom severity did not vary between the follicular and luteal phases. However, a more negative ERN was associated with greater checking symptoms in the luteal phase of the menstrual cycle, even when controlling for ERN amplitude in the follicular phase. Moreover, changes in checking symptoms between phases were associated with phase-related changes in the ERN. Finally, a significant mediation model was found such that the ERN measured in the luteal phase mediated the association between progesterone in the luteal phase and checking symptoms in the luteal phase. Collectively, the present findings suggest that levels of progesterone in the luteal phase could impact checking symptoms by modulating response monitoring and sensitivity to errors, and that fluctuation in the ERN between menstrual cycle phases may play an important role in the expression of anxious and obsessive-compulsive symptoms.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Checking; EEG/ERP; Error-related negativity; Menstrual cycle; OCD; Progesterone

Mesh:

Substances:

Year:  2019        PMID: 30721837      PMCID: PMC6450738          DOI: 10.1016/j.psyneuen.2019.01.027

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  53 in total

1.  Female reproductive cycle and obsessive-compulsive disorder.

Authors:  Javier Labad; José Manuel Menchón; Pino Alonso; Cinto Segalàs; Susana Jiménez; Julio Vallejo
Journal:  J Clin Psychiatry       Date:  2005-04       Impact factor: 4.384

2.  Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone.

Authors:  Rebecca R Klatzkin; A Leslie Morrow; Kathleen C Light; Cort A Pedersen; Susan S Girdler
Journal:  Psychoneuroendocrinology       Date:  2006-10-12       Impact factor: 4.905

3.  Error-related brain activity in obsessive-compulsive undergraduates.

Authors:  Greg Hajcak; Robert F Simons
Journal:  Psychiatry Res       Date:  2002-05-15       Impact factor: 3.222

4.  Development and validation of new anxiety and bipolar symptom scales for an expanded version of the IDAS (the IDAS-II).

Authors:  David Watson; Michael W O'Hara; Kristin Naragon-Gainey; Erin Koffel; Michael Chmielewski; Roman Kotov; Sara M Stasik; Camilo J Ruggero
Journal:  Assessment       Date:  2012-07-20

5.  Error-related negativity abnormalities in generalized anxiety disorder and obsessive-compulsive disorder.

Authors:  Zeping Xiao; Jijun Wang; Ming Zhang; Hui Li; Yingying Tang; Yuan Wang; Qing Fan; John A Fromson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-11-24       Impact factor: 5.067

6.  Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder.

Authors:  Kate Dimond Fitzgerald; Robert C Welsh; William J Gehring; James L Abelson; Joseph A Himle; Israel Liberzon; Stephan F Taylor
Journal:  Biol Psychiatry       Date:  2005-02-01       Impact factor: 13.382

Review 7.  Hormonal Cycles, Brain Network Connectivity, and Windows of Vulnerability to Affective Disorder.

Authors:  Joseph M Andreano; Alexandra Touroutoglou; Brad Dickerson; Lisa Feldman Barrett
Journal:  Trends Neurosci       Date:  2018-09-25       Impact factor: 13.837

8.  Obsessive-compulsive disorder and female reproductive cycle events: results from the OCD and reproduction collaborative study.

Authors:  Valeria Guglielmi; Nienke C C Vulink; Damiaan Denys; Ying Wang; Jack F Samuels; Gerald Nestadt
Journal:  Depress Anxiety       Date:  2014-01-13       Impact factor: 6.505

9.  Overactive performance monitoring in obsessive-compulsive disorder: ERP evidence from correct and erroneous reactions.

Authors:  Tanja Endrass; Julia Klawohn; Fanny Schuster; Norbert Kathmann
Journal:  Neuropsychologia       Date:  2007-12-14       Impact factor: 3.139

10.  Estradiol reduces anxiety- and depression-like behavior of aged female mice.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Physiol Behav       Date:  2009-10-03
View more
  3 in total

1.  Hormonal contraceptive use moderates the association between worry and error-related brain activity.

Authors:  Courtney C Louis; Chelsea Kneip; Tim P Moran; Adriene M Beltz; Kelly L Klump; Jason S Moser
Journal:  Int J Psychophysiol       Date:  2021-11-29       Impact factor: 2.903

Review 2.  Psychiatric Symptoms Across the Menstrual Cycle in Adult Women: A Comprehensive Review.

Authors:  Ariel B Handy; Shelly F Greenfield; Kimberly A Yonkers; Laura A Payne
Journal:  Harv Rev Psychiatry       Date:  2022 Mar-Apr 01       Impact factor: 3.732

3.  Sex Differences in Anxiety: An Investigation of the Moderating Role of Sex in Performance Monitoring and Attentional Bias to Threat in High Trait Anxious Individuals.

Authors:  Natalie Strand; Lin Fang; Joshua M Carlson
Journal:  Front Hum Neurosci       Date:  2021-05-20       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.